Normal office hours

Monday – Friday
8.15 – 17.30

Evening office hours
Mittwoch 8.15 – 20.00

    Get in touch

    with us

    Call us at +41 44 533 81 00 or fill out the adjoining form. We are here to help you.

    Please select the topic for which we may call you:

    Appointments that are not kept must be charged for.

    * This information must be provided.



    Dear patient

    If you have a cold, sore throat, cough, fever, or loss of sense of smell or taste, do not visit our office. Stay home and contact your primary care physician if symptoms worsen.

    As mandated by the Federal Council and the Department of Health, we are doing everything possible to ensure that the risk of contracting COVID-19 is minimized in our office space at Seefeldstrasse 214. Please follow the special instructions on site.

    If you are unsure for any reason, please call the Breast Center 044 533 81 00 immediately. If in doubt, have a doctor connect you.

    We are here for you!

    Your team
    from Brust-Zentrum Zürich

    Am I a patient at risk?

    I had breast cancer – but I feel healthy now and my follow-up care has been unremarkable recently – am I in the risk group?

    The answer is no. Women after breast cancer are not more likely to get infectious diseases. They are now just as healthy as their neighbor and should feel that way.
    This is also true for women who have had chemotherapy in the past. Your immune system has been impaired by chemotherapy only for a short period of time – usually you can assume that with the recovery of the white blood cells (leukocytes) a proper immune defense is in place.

    I am taking anti-hormonal therapy – am I at risk?

    No – women on or following anti-hormonal therapy (e.g. Tamoxifen/Nolvadex, Anastrozole/Arimidex, Letrozole/Femara, Exemestane/Aromasin, Faslodex/Fulvestrant) are no longer at risk.

    I have finished my chemotherapy and am receiving infusions with antibodies (e.g. Trastuzumab/Herceptin or Pertuzumab/Perjeta) – am I at risk?

    No – as long as your blood count has recovered from chemotherapy, you are not at increased risk.

    Who are those women we need to classify as at risk?

    a) Patients who are currently receiving chemotherapy.
    b) Patients taking so-called CDK4/6 inhibitors (Palbociclib/Ibrance, Ribociclib/ Kisqali, Abemaciclib/Vercenios).
    c) Patients with advanced disease who require long-term therapies – e.g. everolimus/finitor, alpelisib/picray, cortisone preparations.

    Patients who fall under category 4: please contact your treating oncologist.

    Further information can be found under Krebsliga.

    x  Powerful Protection for WordPress, from Shield Security
    This Site Is Protected By
    Shield Security